The failure of torcetrapib - Was it the molecule or the mechanism?

被引:227
作者
Tall, Alan R. [1 ]
Yvan-Charvet, Laurent [1 ]
Wang, Nan [1 ]
机构
[1] Columbia Univ Coll Phys & Surg, New York, NY 10032 USA
关键词
D O I
10.1161/01.ATV.0000256728.60226.77
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:257 / 260
页数:4
相关论文
共 24 条
[1]   Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment - Individual patient meta-analysis of 13,677 subjects [J].
Boekholdt, SM ;
Sacks, FM ;
Jukema, JW ;
Shepherd, J ;
Freeman, DJ ;
McMahon, AD ;
Cambien, F ;
Nicaud, V ;
de Grooth, GJ ;
Talmud, PJ ;
Humphries, SE ;
Miller, GJ ;
Eiriksdottir, G ;
Gudnason, V ;
Kauma, H ;
Kakko, S ;
Savolainen, MJ ;
Arca, M ;
Montali, A ;
Liu, S ;
Lanz, HJ ;
Zwinderman, AH ;
Kuivenhoven, JA ;
Kastelein, JJP .
CIRCULATION, 2005, 111 (03) :278-287
[2]   MOLECULAR-BASIS OF LIPID TRANSFER PROTEIN-DEFICIENCY IN A FAMILY WITH INCREASED HIGH-DENSITY LIPOPROTEINS [J].
BROWN, ML ;
INAZU, A ;
HESLER, CB ;
AGELLON, LB ;
MANN, C ;
WHITLOCK, ME ;
MARCEL, YL ;
MILNE, RW ;
KOIZUMI, J ;
MABUCHI, H ;
TAKEDA, R ;
TALL, AR .
NATURE, 1989, 342 (6248) :448-451
[3]   Raising high-density lipoprotein in humans through inhibition of cholesteryl ester transfer protein: An initial multidose study of torcetrapib [J].
Clark, RW ;
Sutfin, TA ;
Ruggeri, RB ;
Willauer, AT ;
Sugarman, ED ;
Magnus-Aryitey, G ;
Cosgrove, PG ;
Sand, TM ;
Wester, RT ;
Williams, JA ;
Perlman, ME ;
Bamberger, MJ .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (03) :490-497
[4]   A prospective study of HDL-C and cholesteryl ester transfer protein gene mutations and the risk of coronary heart disease in the elderly [J].
Curb, JD ;
Abbott, RD ;
Rodriguez, BL ;
Masaki, K ;
Chen, R ;
Sharp, DS ;
Tall, AR .
JOURNAL OF LIPID RESEARCH, 2004, 45 (05) :948-953
[5]   Efficacy and safety of torcetrapib, a novel cholesteryl ester transfer protein inhibitor, in individuals with below-average high-density lipoprotein cholesterol levels [J].
Davidson, Michael H. ;
McKenney, James M. ;
Shear, Charles L. ;
Revkin, James H. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 48 (09) :1774-1781
[6]   Efficacy and safety of a novel cholesteryl ester transfer protein inhibitor, JTT-705, in humans - A randomized phase II dose-response study [J].
de Grooth, GJ ;
Kuivenhoven, JA ;
Stalenhoef, AFH ;
de Graaf, J ;
Zwinderman, AH ;
Posma, JL ;
van Tol, A ;
Kastelein, JJP .
CIRCULATION, 2002, 105 (18) :2159-2165
[7]   DECREASED EARLY ATHEROSCLEROTIC LESIONS IN HYPERTRIGLYCERIDEMIC MICE EXPRESSING CHOLESTERYL ESTER TRANSFER PROTEIN TRANSGENE [J].
HAYEK, T ;
MASUCCIMAGOULAS, L ;
JIANG, X ;
WALSH, A ;
RUBIN, E ;
BRESLOW, JL ;
TALL, AR .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (04) :2071-2074
[8]   AN INTERACTION BETWEEN THE HUMAN CHOLESTERYL ESTER TRANSFER PROTEIN (CETP) AND APOLIPOPROTEIN-A-I GENES IN TRANSGENIC MICE RESULTS IN A PROFOUND CETP-MEDIATED DEPRESSION OF HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL LEVELS [J].
HAYEK, T ;
CHAJEKSHAUL, T ;
WALSH, A ;
AGELLON, LB ;
MOULIN, P ;
TALL, AR ;
BRESLOW, JL .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (02) :505-510
[9]   ATHEROSCLEROTIC DISEASE IN MARKED HYPERALPHALIPOPROTEINEMIA - COMBINED REDUCTION OF CHOLESTERYL ESTER TRANSFER PROTEIN AND HEPATIC TRIGLYCERIDE LIPASE [J].
HIRANO, K ;
YAMASHITA, S ;
KUGA, Y ;
SAKAI, N ;
NOZAKI, S ;
KIHARA, S ;
ARAI, T ;
YANAGI, K ;
TAKAMI, S ;
MENJU, M ;
ISHIGAMI, M ;
YOSHIDA, Y ;
KAMEDATAKEMURA, K ;
HAYASHI, K ;
MATSUZAWA, Y .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (11) :1849-1856
[10]   DELAYED CATABOLISM OF HIGH-DENSITY-LIPOPROTEIN APOLIPOPROTEIN-A-I AND APOLIPOPROTEIN-A-II IN HUMAN CHOLESTERYL ESTER TRANSFER PROTEIN-DEFICIENCY [J].
IKEWAKI, K ;
RADER, DJ ;
SAKAMOTO, T ;
NISHIWAKI, M ;
WAKIMOTO, N ;
SCHAEFER, JR ;
ISHIKAWA, T ;
FAIRWELL, T ;
ZECH, LA ;
NAKAMURA, H ;
NAGANO, M ;
BREWER, HB .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (04) :1650-1658